Premium
Continuing Professional Development
Author(s) -
Vanessa Jordan
Publication year - 2017
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/ceo.13029
Subject(s) - medicine , citation , continuing professional development , continuing education , professional development , library science , medical education , computer science
Achieved 50% reduction in pain with diclofenac gel or solution Approximately 60% of individuals had at least a 50% reduction in pain if they were given topical diclofenac gel or solution. This was a significantly higher proportion than those receiving placebo, where ~50% had a reduction in pain. This was based on six trials including 2342 participants. There were 29 studies reporting on localised adverse events. There was a relatively high incidence of localised adverse events with high levels also reported in the placebo groups. Dry skin was the most commonly reported reaction to the topical NSAID. With some participants reporting rash and erythema. Fourteen studies reported on systemic adverse events including headache, diarrhoea and dyspepsia but the incidence of these were below 10% for the study populations. Achieved 50% reduction in pain with ketoprofen gel Approximately 63% of individuals had at least a 50% reduction in pain if they are given topical ketoprofen gel. This was a significantly higher proportion than those receiving placebo, where ~48% had a reduction in pain. This was based on evidence from four trials including 2573 participants.